-+ 0.00%
-+ 0.00%
-+ 0.00%

Aurinia completes tender offer for Kezar, wins 80% of shares tendered

PUBT·05/19/2026 12:33:10
Listen to the news
Aurinia completes tender offer for Kezar, wins 80% of shares tendered
  • Aurinia Pharmaceuticals completed its tender offer for Kezar Life Sciences, with 5,927,580 shares tendered, representing 80.24% of Kezar’s outstanding shares.
  • The tendered shares had an aggregate value of about $41.23 million.
  • The offer price was $6.96 in cash per share, with one non-transferable contingent value right issued for each share tendered.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurinia Pharmaceuticals Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202605190830NEWSFILECNPR____20260519_297815_1) on May 19, 2026, and is solely responsible for the information contained therein.